In Veritas Valuation
IVME Stock | USD 0.0001 0.00 0.00% |
In Veritas seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of In Veritas Medical from examining the firm fundamentals such as Current Valuation of 8.6 K, price to earning of (0.01) X, and Net Income of (3.67 M) as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting In Veritas' valuation include:
Enterprise Value 8.6 K | Enterprise Value Ebitda (2.17) | Price Sales 0.1429 |
Overvalued
Today
Please note that In Veritas' price fluctuation is very steady at this time. Calculation of the real value of In Veritas Medical is based on 3 months time horizon. Increasing In Veritas' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IVME stock is determined by what a typical buyer is willing to pay for full or partial control of In Veritas Medical. Since In Veritas is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IVME Stock. However, In Veritas' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The real value of IVME Stock, also known as its intrinsic value, is the underlying worth of In Veritas Medical Company, which is reflected in its stock price. It is based on In Veritas' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of In Veritas' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of In Veritas Medical helps investors to forecast how IVME stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of In Veritas more accurately as focusing exclusively on In Veritas' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use In Veritas' intrinsic value based on its ongoing forecasts of In Veritas' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against In Veritas' closest peers. If more than one evaluation category is relevant for In Veritas we suggest using both methods to arrive at a better estimate.
IVME Valuation Trend
Comparing In Veritas' enterprise value against its market capitalization is a good way to estimate the value of In Veritas Medical uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
In Veritas Total Value Analysis
In Veritas Medical is currently expected to have valuation of 8.6 K with market capitalization of 8.61 K, debt of 1.21 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the In Veritas fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
8.6 K | 8.61 K | 1.21 M |
In Veritas Asset Utilization
One of the ways to look at asset utilization of IVME is to check how much profit was generated for every dollar of assets it reports. In Veritas owns a negative utilization of current and long term assets of -6.48 %, losing $0.0648 for each dollar of current and long term assets held by the firm. Discouraging asset utilization attests that the company is being less productive with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of In Veritas Medical shows how wasteful it operates for each dollar spent on its current and long term assets.In Veritas Profitability Analysis
Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates In Veritas' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in In Veritas and how it compares across the competition.
About In Veritas Valuation
The stock valuation mechanism determines In Veritas' current worth on a weekly basis. Our valuation model uses a comparative analysis of In Veritas. We calculate exposure to In Veritas's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of In Veritas's related companies.Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (1.67) | (1.76) | |
Operating Profit Margin | 0.87 | 1.71 | |
Net Loss | (1.67) | (1.76) | |
Gross Profit Margin | 1.14 | 1.10 |
In Veritas Current Valuation Indicators
Valuation refers to the process of determining the present value of In Veritas Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value IVME we look at many different elements of the entity such as IVME's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as In Veritas, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use In Veritas' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes In Veritas' worth.Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |